Harm Reduction and Recovery Support Services: Complementing and Supporting Pharmacotherapy for Substance Use Disorders
In 2020, 41.1 million Americans needed substance use treatment but less than 10% received care.
Though significant structural barriers to treatment exist, many individuals also may not be ready to engage in treatment. Harm reduction strategies can help prevent overdose and sustain engagement until they are ready for treatment. Recovery support services can promote recovery-readiness before treatment and help facilitate long-term recovery during and after treatment. Both of these approaches can help clinical practices to enhance their recovery-oriented care.
Join us on July 28, 3 p.m. ET for Harm Reduction and Recovery Support Services: Complementing and Supporting Pharmacotherapy for Substance Use Disorders. This webinar will discuss how harm reduction practices and recovery support services can be integrated to support the clinical use of medications for addiction treatment (MAT) and enhance care for people with substance use disorders (SUD).
After attending the webinar, you will be able to:
- Summarize the differences between the acute care treatment model and the recovery-oriented system of care model.
- Recognize the research that supports recovery-oriented and harm reduction approaches.
- Describe the role harm reduction practices and recovery support services can play in supporting clinical use of MAT.
- Identify strategies to implement and sustain harm reduction practices and recovery support services within SUD treatment provider organizations.